VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published Nov 26th-28th; they will resume
distribution on Monday, Dec 1st.
|
 |
| november
25, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Biogen: Eisai Completes Rolling Submission
to US FDA for LEQEMBI IQLIK (lecanemab-irmb)
Supplemental Biologics License Application as
a Subcutaneous Starting Dose for the Treatment
of Early Alzheimer’s Disease Under Fast Track
Status More
- HKeyBio: Launches the HKEY-AIDMD 3.0--a
Next-Generation Platform to Crack the Toughest
Challenge in Autoimmune and Allergy Drug
Development - Multi-target Combination
Strategy Optimization More
- Kelonia Therapeutics: Late-Breaking Oral
Presentation of First-in-Human Data From in
vivo BCMA CAR-T Therapy at the American
Society of Hematology (ASH) 2025 Annual
Meeting More
- Kymera Therapeutics: First Patient Dosed in
BROADEN2 Phase 2b Atopic Dermatitis Clinical
Trial of KT-621, a First-in-Class, Oral STAT6
Degrader More
- NeuroSense: Receives FDA Clearance to
Initiate Pivotal Phase 3 Trial for PrimeC in
ALS More
- 1910: Publishes CANDID-CNS, an AI Model That
Unlocks Beyond Rule of 5 Chemical Space and
Stereochemistry to Predict Blood–Brain Barrier
Penetration More
- Vertero: Initiates Phase 1 Study of VT-5006,
a Selective Small Molecule Therapy for
Parkinson’s Disease More
- Vyome: Appoints Renowned Medical Oncologist,
Dr. Aditya Bardia, as Senior Medical Advisor
to Guide the Development of MFW Program More
|
|
 |
 |
The
Charles River CFO Advantage
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
|
- BYTE51:
Exclusive Pricing on Private Biotech &
VC Intelligence More
- Climb Bio: Inducement Grant Under Nasdaq
Listing Rule 5635(c)(4) More
- CureVac: Financial Results for the Third
Quarter and First Nine Months of 2025 and
Provides Business Updates More
- Dana-Farber Cancer Institute: Awarded $20
Million Grant From the Elaine and Eduardo
Saverin Foundation More
More*
- Enquyst Technologies: Demonstrates
First-in-Class, Chromatography-free Downstream
Processing of a Monoclonal Antibody (mAb) With
Its Patented Isoelectric Point Purification
(IPP) Technology Platform and Announces
Receipt of a National Institute for Innovation
in Manufacturing Biopharmaceutical (NIIMBL)
Led Gates Grand Challenge Program Award More
- IQHQ Halts Development on $1B Fenway Center
Life Sciences Project More*
- JPM
Week Conference Readiness Packages (Big4Bio
Subscriber Discount) More
- MindImmune: Extends Series A to $30M to
Advance Inflammation-Focused Alzheimer’s
Therapy Into the Clinic and Appoints Isaac
Stoner as CEO More
- More on Versant’s Dayra Dawning With $50M
Biogen Pact, Oral Macrocyclic Peptide
Mission More
More
More*
- Nanobiotix: Third Quarter 2025 Operational
and Financial Update Along With 2026 Clinical
Outlook More
- Nuvalent: Closing of Public Offering of
Common Stock and Full Exercise by Underwriters
of Option to Purchase Additional Shares From
Selling Stockholders More
- ProMIS Neurosciences: Reverse Stock Split More
- The One Big Beautiful Bill Act: A Guide
to Small Business Taxes More
- Thermo
Fisher Scientific: Prices Offering of
Euro-Denominated Senior Notes More
|
|
 |
|
- Broad: New AI Model Could Speed Rare Disease
Diagnosis More
- ICYMI: Boston Life Sciences Times Announces
2025 Vanguard Award Winners More
- Moderna Exec Explains Shift to Onshore Manufacturing,
Norwood Investment More*
- More on Sarepta Sharing Positive Safety
Update on DM1 Asset as Arrowhead Snares $200M
Milestone More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: How NAMs Are Rewriting the Rules of
Antibody Discovery Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- M&A in Life Sciences: The Turning
Tide – Why Now is a Strategic Inflection for
Biopharma and Biotech More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning - Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- Jeff Bluestone, Stephen Dilly Talk CEO
Handoff, What’s Next for Sonoma; Scott
Gottlieb’s Next Move More*
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
 |
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Compounding Pharmacy Compliance (Save 10%
with VIP code: 25B4B10) Dec
9-10
- PBM Contracting Summit (Save 10% with VIP
code: 25B4B10) Dec
9-10
- Trade and Channel Strategies (Save 10% with
VIP code: 25B4B10) Dec
9-11
- The Power of Presenting at Biotech Showcase
Dec
10
- Advancing Drug Development Forum Dec
11
- Know Before You Go: AI in 2026 — Signals,
Risks, and Real-World Impact (Pre-JPM Event)
Jan
6
- BLPN Investor Summit Jan
8-10
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
